Literature DB >> 26287799

Encapsulation of N-Diazeniumdiolates within Liposomes for Enhanced Nitric Oxide Donor Stability and Delivery.

Dakota J Suchyta1, Mark H Schoenfisch1.   

Abstract

The rapid decomposition of nitric oxide (NO) donors in aqueous environments remains a limitation for applications requiring extended NO release. Herein, we report the synthesis of dipalmitoylphosphatidylcholine-based liposomes capable of extended NO release using low molecular weight NO donors and a reverse-phase evaporation technique. The encapsulation of the NO donors within the liposomes enabled both prolonged NO release and enhanced storage compared to free NO donors alone. The NO-releasing liposomes also demonstrated enhanced efficacy against human pancreatic cancer cells. These NO-release vehicles represent attractive anticancer therapeutics due to their potential to store the majority of their NO payload until reaching cancerous tissue at which time the lower pH inherent to such environments will trigger an avalanche of NO.

Entities:  

Keywords:  cancer; controlled release; drug delivery; liposome; nitric oxide

Mesh:

Substances:

Year:  2015        PMID: 26287799     DOI: 10.1021/acs.molpharmaceut.5b00248

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  13 in total

1.  Anticancer potency of nitric oxide-releasing liposomes.

Authors:  Dakota J Suchyta; Mark H Schoenfisch
Journal:  RSC Adv       Date:  2017-11-20       Impact factor: 3.361

2.  Encapsulation of a nitric oxide donor into a liposome to boost the enhanced permeation and retention (EPR) effect.

Authors:  Yu Tahara; Takuma Yoshikawa; Hikari Sato; Yukina Mori; Md Hosain Zahangir; Akihiro Kishimura; Takeshi Mori; Yoshiki Katayama
Journal:  Medchemcomm       Date:  2016-12-21       Impact factor: 3.597

3.  Nitric Oxide-Releasing Cyclodextrins.

Authors:  Haibao Jin; Lei Yang; Mona Jasmine R Ahonen; Mark H Schoenfisch
Journal:  J Am Chem Soc       Date:  2018-10-16       Impact factor: 15.419

4.  Controlled release of nitric oxide from liposomes.

Authors:  Dakota J Suchyta; Mark H Schoenfisch
Journal:  ACS Biomater Sci Eng       Date:  2017-07-03

Review 5.  Opportunities for Nitric Oxide in Potentiating Cancer Immunotherapy.

Authors:  Jihoon Kim; Susan N Thomas
Journal:  Pharmacol Rev       Date:  2022-10       Impact factor: 18.923

Review 6.  Nitric Oxide-Releasing Macromolecular Scaffolds for Antibacterial Applications.

Authors:  Lei Yang; Evan S Feura; Mona Jasmine R Ahonen; Mark H Schoenfisch
Journal:  Adv Healthc Mater       Date:  2018-05-14       Impact factor: 9.933

7.  Mode of nitric oxide delivery affects antibacterial action.

Authors:  Jackson R Hall; Kaitlyn R Rouillard; Dakota J Suchyta; Micah D Brown; Mona Jasmine R Ahonen; Mark H Schoenfisc
Journal:  ACS Biomater Sci Eng       Date:  2019-11-13

Review 8.  The evolving landscape for cellular nitric oxide and hydrogen sulfide delivery systems: A new era of customized medications.

Authors:  Kearsley M Dillon; Ryan J Carrazzone; John B Matson; Khosrow Kashfi
Journal:  Biochem Pharmacol       Date:  2020-03-26       Impact factor: 5.858

9.  Nitric Oxide as a Potential Adjuvant Therapeutic for Neuroblastoma: Effects of NO on Murine N2a Cells.

Authors:  Jenna L Gordon; Melissa M Reynolds; Mark A Brown
Journal:  Vet Sci       Date:  2020-04-23

Review 10.  Progress and Promise of Nitric Oxide-Releasing Platforms.

Authors:  Tao Yang; Alexander N Zelikin; Rona Chandrawati
Journal:  Adv Sci (Weinh)       Date:  2018-04-23       Impact factor: 16.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.